Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases
The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.
Related Posts
-
CPAD Has Two Posters Accepted to Alzheimer’s Association International Conference -
“Improving Clinical Trials to Deliver Better Treatments,” as featured in the Spring 2018 edition of “Progress, the research magazine of Parkinson’s UK” -
C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) -
C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)
-
C-Path and FARA announce collaborative data aggregation project for Friedreich’s ataxia